09 August 2013

Ranbaxy to Build New Manufacturing Facility in Malaysia

Kuala Lumpur, Malaysia; Gurgaon, India – 08 August 2013 - Ranbaxy Malaysia Sdn Bhd (RMSB) today announced that it has been allocated the site for setting up its Greenfield manufacturing facility in Malaysia. The Ranbaxy Greenfield facility will be built on an area of around 15 acres with an investment of around US$ 35 million providing employment to over 200 people. This will be Ranbaxy’s second manufacturing plant in Malaysia.

The company signed a ‘letter of offer’ agreement with Kulim Hi Tech Park (KHTP), a wholly owned state agency and industrial park that houses various other leading industries. KHTP is located at Kulim in the state of Kedah, Malaysia. Last year in September, the Government of Malaysia gave an approval to RMSB for setting up a Greenfield manufacturing facility in Malaysia as an Entry Point Project (EPP).

Commenting on the signing ceremony, T. Jeyabalan Thangarajah, Managing Director of RMSB said, “Ranbaxy established its foothold in Malaysia three decades back and since then has been offering high quality, affordable generic medicines to the Malaysian healthcare system. The new Greenfield facility reinforces our long term commitment. ” He further added, “In addition to serving the local market, the new facility will also export products to the ASEAN markets, Middle East, Europe, Sri Lanka, China and other select nations.”

The RMSB new facility would manufacture dosage forms including tablets and capsules primarily in the Cardiovascular, Anti Diabetic, Anti-infective and Gastrointestinal segments. Ranbaxy’s total output in Malaysia will be increased from 1 Billion doses/annum to 3 Billion doses/annum when the new facility is fully operational.

Ranbaxy Malaysia Sdn Bhd (RMSB) is a joint venture company of Ranbaxy Laboratories Limited, India and Malaysian shareholders. Established in 1982, RMSB is today one of the major generic companies in this market. RMSB manufacturing facility in Sungai Petani, Kedah, Malaysia, was commissioned in 1987. RMSB employs over 300 employees in Malaysia.

Ranbaxy Laboratories Limited, India’s largest pharmaceutical company. Ranbaxy serves its customers in over 150 countries and has an expanding international portfolio of affiliates, joint ventures and alliances, ground operations in 43 countries and manufacturing operations in 8 countries. Ranbaxy is a member of the Daiichi Sankyo Group, a leading global pharma innovator headquartered in Tokyo, Japan. 

Source: Ranbaxy